Cargando…
Do electronic medication monitors improve tuberculosis treatment outcomes? Programmatic experience from China
BACKGROUND: In China, an indigenously developed electronic medication monitor (EMM) was used. EMM recorded each time the device was opened (no real time data), offering an indirect measure of tuberculosis treatment adherence. Previous study in China showed that the EMM uptake was satisfactory, missi...
Autores principales: | Wang, Ni, Shewade, Hemant Deepak, Thekkur, Pruthu, Zhang, Hui, Yuan, Yanli, Wang, Xiaomeng, Wang, Xiaolin, Sun, Miaomiao, Huang, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652336/ https://www.ncbi.nlm.nih.gov/pubmed/33166361 http://dx.doi.org/10.1371/journal.pone.0242112 |
Ejemplares similares
-
Electronic medication monitor for people with tuberculosis: Implementation experience from thirty counties in China
por: Wang, Ni, et al.
Publicado: (2020) -
Effect of using electronic medication monitors on tuberculosis treatment outcomes in China: a longitudinal ecological study
por: Wang, Ni, et al.
Publicado: (2021) -
Is It Feasible to Conduct Post-Tuberculosis Assessments at the End of Tuberculosis Treatment under Routine Programmatic Conditions in China?
por: Lin, Yan, et al.
Publicado: (2021) -
Glycemic control monitoring in patients with tuberculosis and diabetes: a descriptive study from programmatic setting in Tamil Nadu, India
por: Gurukartick, J., et al.
Publicado: (2020) -
Screening People with Tuberculosis for High Risk of Severe Illness at Notification: Programmatic Experience from Karnataka, India
por: Shewade, Hemant Deepak, et al.
Publicado: (2021)